Ruxolitinib Cream Price in 2025: What are the expected future price fluctuations and purchasing channels?

Ruxolitinib cream (Opzelura) is a topical JAK inhibitor mainly used to treat vitiligo and mild to moderate atopic dermatitis. The drug was developed by the American pharmaceutical company Incyte and has been approved for marketing in the United States and some countries. In the domestic market, as of 2025, ruxolitinib cream has not yet received marketing approval from the National Food and Drug Administration (NMPA). Therefore, if patients want to use the drug, they still need to rely on overseas drug purchases.

In2025, the price of ruxolitinib cream will still maintain a large difference. The original research version is produced by Incyte. The price of one bottle is about RMB 10,000, which is relatively high. It is mainly supplied to the European and American markets. In overseas markets, many generic drug manufacturers have launched more affordable alternatives. Among them, the generic version of ruxolitinib cream produced by the Bangladeshi pharmaceutical company Everest/Yapan (Everest/Yapan) sells for about 500 to 600 yuan, about one-tenth of the original drug, and has become the first choice of many patients.

It is expected that the price of ruxolitinib cream will be affected by multiple factors in the future, including the launch of more generic versions, changes in international drug approval policies, and whether the drug will be introduced domestically. Once it is approved for marketing in China and enters the medical insurance system, the price may drop, but it will still take some time. In the short term, the prices of original drugs will not fluctuate much, while generic versions may have room for a slight decline due to intensified competition.

Current purchasing channels mainly include overseas pharmacies, e-commerce platform purchasing agents, overseas medical institutions or domestic platforms that provide overseas pharmaceutical services. Since overseas or cross-border drug purchases are involved, patients are advised to go through formal channels to ensure that the sources of drugs are legal, safe and effective. At the same time, before using ruxolitinib cream, you should consult a professional doctor to confirm the indications and usage, and avoid blind use on your own to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.opzelura.com/